NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email All NIL deals must now pass through a process run by Deloitte. It threatens to significantly scale back the millions of dollars being handed to athletes from booster-backed collectives.Read More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026